INS and Insulin resistance: It has further been demonstrated that glycine enhances insulin secretion directly from human β cells of T2D and non-T2D donors (5) and that circulating levels of glycine are inversely correlated with T2D risk (6–11), insulin resistance (12–14), impaired glucose tolerance (15, 16), and obesity (14, 17).